A licensing board or disciplinary subcommittee shall not issue a letter of concern or similar form of reprimand, nor revoke, fail to renew, suspend, or take any action against a health care provider's license issued under Title 34, based solely on the health care provider's recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product, or device. An entity responsible for Medicare certification shall not reprimand or take action against a health care provider's Medicare certification based solely on the health care provider's recommendation that a patient have access to an investigational drug, biological product, or device.
Structure Code of Alabama
Title 22 - Health, Mental Health, and Environmental Control.
Title 1 - Health and Environmental Control Generally.
Chapter 5D - Gabe Griffin Right to Try Act.
Section 22-5D-1 - Short Title.
Section 22-5D-2 - Definitions.
Section 22-5D-4 - Coverage and Costs.
Section 22-5D-5 - Liability of Heirs.
Section 22-5D-6 - Effect on License or Certification.
Section 22-5D-7 - Relation to Other Laws and Professional Obligations.
Section 22-5D-8 - Additional Coverage Not Required Under Medicaid.
Section 22-5D-9 - Blocking Access Prohibited; Counseling, etc., Permitted.
Section 22-5D-10 - Private Cause of Action Not Created Under Chapter.